# Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use

> **NCT04595084** · NA · COMPLETED · sponsor: **Cambridge Health Alliance** · enrollment: 113 (actual)

## Conditions studied

- Depression
- Anxiety
- Substance Use
- Stress, Psychological
- Stress, Emotional
- Alcohol Use, Unspecified
- Drug Use
- Covid19

## Interventions

- **BEHAVIORAL:** Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell
- **BEHAVIORAL:** Internet Cognitive Behavioral Therapy plus CHAMindWell
- **BEHAVIORAL:** CHAMindWell

## Key facts

- **NCT ID:** NCT04595084
- **Lead sponsor:** Cambridge Health Alliance
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2023-03-06
- **Final completion:** 2023-03-06
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595084, "Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04595084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*